Amyra Biotech AG
Solutions For Gluten Induced Disorders
AMYRA is developing therapeutic product applications for the treatment of celiac disease and gluten sensitivity, which represent major public health issues. Both conditions are triggered by the ingestion of gluten, which is ubiquitously present in the Western diet and thus almost impossible to avoid.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
31.10.2024
AlveoliX and AMYRA report breakthroughs (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Amyra Biotech AG
Solutions For Gluten Induced Disorders
Website:
www.amyra.com/
Headquarter:
Basel
Foundation Date:
May 2014
Technology:
- Biotech
Sectors:
- Biotech
- Food